Hop derived flavonoid xanthohumol inhibits endothelial cell functions<i>via</i>AMPK activation

Cristina Gallo, Katiuscia Dallaglio, Barbara Bassani, Teresa Rossi, Armando Rossello, Douglas M. Noonan, Gabriele D’Uva, Antonino Bruno, Adriana Albini

Oncotarget · 2016 · 36 citations · 41 references

DOIFull text

Open access

Concepts

Abstract

// Cristina Gallo 1 , Katiuscia Dallaglio 1 , Barbara Bassani 2 , Teresa Rossi 1 , Armando Rossello 3 , Douglas M. Noonan 4 , Gabriele D&rsquo;Uva 2 , Antonino Bruno 2 , Adriana Albini 2 1 IRCCS &ldquo;Istituto in Tecnologie Avanzate e Modelli Assistenziali in Oncologia&rdquo; Arcispedale S. Maria Nuova, Reggio Emilia, Italy 2 Scientific and Technology Pole, IRCCS MultiMedica, Milan, Italy 3 Department of Pharmacy, Pisa University, Pisa, Italy 4 Department of Biotechnologies and Life Sciencies, University of Insubria, Varese, Italy Correspondence to: Adriana Albini, email: albini.adriana@gmail.com Keywords: angiogenesis, xanthohumol, AMPK, endothelial cells, polyphenols Received: March 25, 2016&emsp;&emsp;&emsp;&emsp; Accepted: June 06, 2016&emsp;&emsp;&emsp;&emsp; Published: August 1, 2016 ABSTRACT Angiogenesis, a process characterized by the formation of new blood vessels from pre-existing ones, is a crucial step in tumor growth and dissemination. Recently, increased attention has been addressed to the ability of flavonoids to prevent cancer by suppressing angiogenesis, strategy that we named &ldquo;angioprevention&rdquo;. Several natural compounds exert their anti-tumor properties by activating 5&rsquo; adenosine monophosphate-activated protein kinase (AMPK), a key regulator of metabolism in cancer cells. Drugs with angiopreventive activities, in particular metformin, regulate AMPK in endothelial cells. Here we investigated the involvement of AMPK in the anti-angiogenic effects of xanthohumol (XN), the major prenylated flavonoid of the hop plant, and mechanisms of action. The anti-angiogenic activity of XN was more potent than epigallocatechin-3-gallate (EGCG). Treatment of endothelial cells with XN led to increased AMPK phosphorylation and activity. Functional studies using biochemical approaches confirmed that AMPK mediates XN anti-angiogenic activity. AMPK activation by XN was mediated by CAMMK&beta;, but not LKB1. Analysis of the downstream mechanisms showed that XN-induced AMPK activation reduced nitric oxide (NO) levels in endothelial cells by decreasing eNOS phosphorylation. Finally, AKT pathway was inactivated by XN as part of its anti-angiogenic activity, but independently from AMPK, suggesting that these two signaling pathways proceed autonomously. Our study dissects the molecular mechanism by which XN exerts its potent anti-angiogenic activity, pointing out AMPK as a crucial signal transducer.

References

41